期刊簡介 | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | NEUROPSYCHOPHARMACOLOGY LetPub Score 8.7
50 ratings
Rate
Reputation 10.0 Influence 8.1 Speed 7.0 | |||||||||||||||||||||
期刊簡稱 | NEUROPSYCHOPHARMACOL | |||||||||||||||||||||
ISSN | 0893-133X | |||||||||||||||||||||
E-ISSN | 1740-634X | |||||||||||||||||||||
h-index | 204 | |||||||||||||||||||||
CiteScore |
| |||||||||||||||||||||
自引率 (2023-2024) | 1.50%自引率趨勢 | |||||||||||||||||||||
掲載範囲 |
| |||||||||||||||||||||
官方網站 | https://www.nature.com/npp | |||||||||||||||||||||
在線稿件提交 | https://mts-npp.nature.com/ | |||||||||||||||||||||
開放訪問 | No | |||||||||||||||||||||
出版商 | Springer Nature | |||||||||||||||||||||
主題領域 | 医学 | |||||||||||||||||||||
出版國/地區 | ENGLAND | |||||||||||||||||||||
發行頻率 | 月刊 | |||||||||||||||||||||
創刊年 | 1993 | |||||||||||||||||||||
每年文章數 | 175每年文章數趨勢 | |||||||||||||||||||||
黃金OA百分比 | 35.81% | |||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| |||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | |||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0893-133X%5BISSN%5D | |||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | |||||||||||||||||||||
競爭力 * | 來自作者的數據: About 28.75% | |||||||||||||||||||||
參考鏈接 |
| |||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[NEUROPSYCHOPHARMACOLOGY] 的評論 | 撰寫評論 |
作者: 璃月琦巧 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-27 21:05:10 評論於 Focused research direction: sharing experiences in the field of mental health: submitted(0) 讚! | 璃月琦巧 |
作者: 润宾来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-27 10:00:01 評論於 Hello, just wanted to ask how long have you been using it. I am currently waiting for the proof as well(0) 讚! | 润宾来了 |
作者: yuyuyu111 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-07-16 13:44:07 評論於 Revision Received 19th May 23 (Revised once) Waiting for Revision 4th Apr 23 Decision Made 4th Apr 23 Under Review 21st Feb 23 Submission 12th Feb 23 Revision Received 7th Jul 23 (Revised once) Waiting for Revision 3rd Jul 23 Decision Made 3rd Jul 23 Under Review 13th Jun 23 Submission 11th Jun 23 Manuscript Deleted 19th May 23 Submission 19th May 23 Revision Received 10th Jul 23 (Revised twice) Post Decision 10th Jul 23 Under Review 7th Jul 23 Submission 7th Jul 23 Successfully Received(0) 讚! | yuyuyu111 |
作者: 东霞mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-19 20:08:52 評論於 How long does it usually take for something to be under review?(0) 讚! | 东霞mio |
作者: 东霞mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-19 19:45:24 評論於 It has been half a month since I submitted, but I haven't received any news. May I ask if I should continue waiting?(0) 讚! | 东霞mio |
作者: 东霞mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-19 15:33:27 評論於 It has been half a month since the submission was made, and there is still no news. Can my colleagues give some suggestions on whether this is a polite rejection? Is it necessary to continue waiting?(0) 讚! | 东霞mio |
作者: 八荒建玲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-29 18:23:15 評論於 Excuse me, what does this status indicate? How long did it take for you to submit it for review later?(0) 讚! | 八荒建玲 |
作者: 八荒建玲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-29 08:25:21 評論於 How long did you submit it for review later?(0) 讚! | 八荒建玲 |
作者: 华清柔怀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-25 11:57:10 評論於 How long does it take to receive the proof email after accepting?(0) 讚! | 华清柔怀 |
作者: 曼雁小娘子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-29 13:35:42 評論於 Do you require full membranes for Western blot in this journal?(0) 讚! | 曼雁小娘子 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:17:11 評論於 There is no fixed requirement for the discussion, so feel free to write it based on your own situation(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:45:23 評論於 Contrary to the introduction which is typically structured like an inverted pyramid, the discussion section expands from small to large in a funnel shape. Starting from the rationale of each research result, anomalies, and underlying principles, a detailed analysis is gradually conducted. After laying the groundwork, the main conclusions of the paper can be naturally introduced for discussion, followed by further expansion to point out the importance/significance/generality/application value of the research(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 19:57:51 評論於 How many paragraphs should a discussion generally be divided into?(0) 讚! | 上清雨真 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 16:12:53 評論於 What is the difference between an introduction and a discussion?(0) 讚! | 深渊兴业 |
作者: 东风太枝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-08 09:26:44 評論於 It has been 11 days since submission. How much longer until it is sent for review?(0) 讚! | 东风太枝 |
作者: 玄虚琛丽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-05 16:37:07 評論於 What original data do we need to prepare?(0) 讚! | 玄虚琛丽 |
作者: 凌霄温韦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-03 23:45:20 評論於 Can you provide the PMID for this? I want to learn more(0) 讚! | 凌霄温韦 |
作者: 一只安娴呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-10-24 17:19:02 評論於 Review speed: 2.0 | Submission success rate: 50.0 Experience sharing: Compound Chinese medicine preparation(0) 讚! | 一只安娴呀 |
作者: 运凯小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-09-30 11:16:02 評論於 I don't know what to do(0) 讚! | 运凯小可爱 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-12-26 16:50:23 評論於 Review speed: 2.0 | Submission acceptance rate: 5.0 Experience sharing: The first review of our submission took 52 days, and it took 35 days for the second review after major revisions. Now the editor-in-chief asked for minor revisions without an external review. This journal is quite good. Several reviewers are experts in the field, and the questions they raise are very professional. I have benefited a lot(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-11-15 18:48:36 評論於 Review speed: 3.0 | Submission hit rate: 5.0 Experience sharing: Several departments in our school have submitted over 20 articles, but only one has been accepted. It's very difficult!(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-11-06 21:36:08 評論於 Review Speed: 1.0 | Submission Success Rate: 5.0 Experience Sharing: A streak of hitting the mark on the first try, getting three in a row, it's like playing a game. Definitely lucky, or just plain stupid. It's really difficult, unless you know someone, or have a lot of colorful pictures(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-10 21:37:54 評論於 Review speed: 2.0 | Submission success rate: 75.0 Experience sharing: I have hit three papers above, which is relatively easy, you can come here to play casually(0) 讚! | 凌霄高洁 |
作者: 凌波安兴 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-04-14 16:47:27 評論於 It doesn't seem too difficult to find references for it, the required amount of data is not very large, as long as you refine it and have innovation, it shouldn't be difficult(0) 讚! | 凌波安兴 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-01-05 10:48:37 評論於 Under review for 12 days, then rejected. The reviewers for the journal are all highly respected experts, and their questions are challenging and very professional(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us